ArticleBioMed research international2014
Novel psychoactive substances in young adults with and without psychiatric comorbidities.
Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 119 citations in OpenAlex.
- Emergency Department presentations due to new psychoactive substances (NPS) and other illicit drugs: a clinical and toxicological study on recreational drug toxicity in Italy.International journal of legal medicine · 2026Observational
- New Synthetic Compounds with Psychoactive Action-Preliminary Results Among Primary and High School Students on the Territory of Novi Sad.Medicines (Basel, Switzerland) · 2025Article
- Alcohol Use Disorders and Suicidal Behaviour: A Narrative Review.Actas espanolas de psiquiatria · 2025Review
- Factors associated with the use of benzodiazepine and opioid prescription drug in the student population: a cross-sectional study.Scientific reports · 2024Article
- Psychotic symptoms and its associated factors relating to psychoactive substance use among the youth population in Northwest Ethiopia.Frontiers in psychiatry · 2023Article
- Analytically confirmed presence of psychoactive substances, especially new psychoactive substances in a group of patients hospitalized with mental and behavioural disorders due to the use of psychoactive substances diagnosis.International journal of occupational medicine and environmental health · 2022Article
- Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders.International journal of environmental research and public health · 2022Article
- Akathisia after chronic usage of synthetic cathinones: A case study.Frontiers in psychiatry · 2022Article
- Pathological Delta Oscillations in Hallucinogen Persisting Perception Disorder: A Case Report.Frontiers in psychiatry · 2022Article
- Identification of 'Voodoo': an emerging substance of abuse in Egypt.International journal of environmental analytical chemistry · 2022Article
- Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances.Brain sciences · 2020Article
- Novel Psychoactive Substances in Custodial Settings: A Mixed Method Investigation on the Experiences of People in Prison and Professionals Working With Them.Frontiers in psychiatry · 2020Article
- Frequency and Predictors of Alcohol-Related Outcomes Following Alcohol Residential Rehabilitation Programs: A 12-Month Follow-Up Study.International journal of environmental research and public health · 2019Article
- Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.Brain sciences · 2018Review
- Octodrine: New Questions and Challenges in Sport Supplements.Brain sciences · 2018Article
- Alcohol drinking patterns in young people: A survey-based study.Journal of health psychology · 2017Article
- Drunkorexia: an emerging trend in young adults.Eating and weight disorders : EWD · 2017Article
- Problematic Alcohol Use among University Students.Frontiers in psychiatry · 2017Article
- The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol.Systematic reviews · 2016Article
- Use of novel psychoactive substances by inpatients on general adult psychiatric wards.BMJ open · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 9 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveComorbidities between psychiatric diseases and consumption of traditional substances of abuse (alcohol, cannabis, opioids, and cocaine) are common. Nevertheless, there is no data regarding the use of novel psychoactive substances (NPS) in the psychiatric population. The purpose of this multicentre survey is to investigate the consumption of a wide variety of psychoactive substances in a young psychiatric sample and in a paired sample of healthy subjects.
methodsA questionnaire has been administered, in different Italian cities, to 206 psychiatric patients aged 18 to 26 years and to a sample of 2615 healthy subjects matched for sex, gender, and living status.
resultsAlcohol consumption was more frequent in the healthy young population compared to age-matched subjects suffering from mental illness (79.5% versus 70.7%; P < 0.003). Conversely, cocaine and NPS use was significantly more common in the psychiatric population (cocaine 8.7% versus 4.6%; P = 0.002) (NPS 9.8% versus 3%; P < 0.001).
conclusionsThe use of novel psychoactive substances in a young psychiatric population appears to be a frequent phenomenon, probably still underestimated. Therefore, careful and constant monitoring and accurate evaluations of possible clinical effects related to their use are necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.